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The novel Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) has so far resulted in more than 300,000 reported confirmed cases of Coronavirus virus disease 2019 (COVID-19) and about
15,000 deaths. Today's very high degree of international interconnectedness and mobility has favored the truly rapid global spread of
this novel virus as COVID-19 cases have been so far reported from almost every country on earth (190 out of 195 countries recognized by
the United Nations) [1]. Severe respiratory illness and acute respiratory
distress syndrome (ARDS), mostly observed in older adults, that have in
many instances in several countries overloaded hospital capacities have
so far dominated the media reports and the clinical literature on
COVID-19 [2].
Infections with SARS-CoV-2 in children were indeed absent or rarely
noted in the early reports, and the associated morbidity in COVID-19
was deemed as mostly mild [3]. In particular in comparison to adults,
children with COVID-19 were deemed to have milder illness and a
better prognosis [4]. Moreover, vertical transmission of SARS-CoV-2
has so far not been documented, and disease in newborns has been
considered as occurring only very rarely [5–7]. As a result, it was even
wondered if children might be less susceptible to this novel infectious
disease [8]. This first glance at COVID-19 in children is of course reassuring on the surface especially for those providing health care for
children, yet it begs the question if there is more to see and to learn
about pediatric COVID-19 associated clinical disease and the epidemiology of SARS-CoV-2 infections in children?
Forthcoming literature with more detailed data on pediatric morbidity during the progressing and accelerating COVID-19 pandemic
allow now for a more nuanced picture [9,10]. In the hitherto largest
pediatric COVID-19 study that analyzed 2143 children with laboratoryconfirmed or suspected cases most pediatric patients (94.1%) were diagnosed as asymptomatic, or with mild or moderate disease [10]. In
fact, 13% of laboratory-confirmed cases were asymptomatic which is
notable as this is certainly an underestimation of the true rate of
asymptomatic infection, since many children without symptoms are
unlikely to be tested for obvious reasons. Recent virologic data demonstrated that such asymptomatic or oligosymptomatic individuals
carry potentially infectious SARS-CoV-2 particles in their nasopharyngeal secretions thereby very likely contributing to early transmission
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to close contacts [11,12]. In addition, the evidence of fecal shedding of
SARS-CoV-2 in the stool of an asymptomatic child for a prolonged
period raises the concern that infants and children who are not toilettrained could facilitate fecal-oral transmission of the virus [13]. The
potentially prolonged shedding of the virus in nasal secretions and stool
of children and infants has substantial implications for spread of the
virus in daycare centers, schools, and in the home. Consequently,
children and infants may play a pivotal role in community-based
transmission of SARS-CoV-2.
Severe pediatric COVID-19 infections are seemingly rare, in this sofar largest pediatric COVID-19 analysis less than 1 in 10 children diagnosed with COVID-19 developed a severe and critical illness and only
one child died [10]. However, it has recently been questioned if such
numbers reflect the real burden of severe COVID-19 disease in children
[14]. Using the ratio of COVID-19 to influenza cases identified in an
early retrospective surveillance study in China [3], it was estimated
that the actual number of severe pediatric cases and mildly infected
children may have been significantly larger (by a factor of several
hundreds and several thousands, respectively) compared to what had
been registered suggesting that the force of infection from children may
have been grossly underestimated [14]. In regards of clinical impact,
the available data suggest that the proportion of severe and critical
cases seems to be inversely related to age suggesting that young children, and in particular infants and pre-school children, could be more
vulnerable to COVID-19 related morbidity [10]. Thus, clinicians caring
for children should be wary of subgroups of children who can be at an
increased risk for more significant illness, as particularly younger age,
underlying pulmonary pathology, and many immunocompromising
conditions have also been associated with more severe outcomes with
other coronavirus infections in children [15].
Much has been learnt about SARS-CoV-2 and COVID-19 in a very
short time, yet there is still much that we need to learn about the impact
of this virus on children, as well as the impact of children on viral
spread. While the focus during pandemics is frequently largely determined by the pandemic's impact on the individuals who utilize the
highest resources or on the economically productive age groups, rigorously gauging the impact of COVID-19 on children will be important
to accurately model the pandemic and to ensure that appropriate
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resources are allocated to children requiring care.
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